Economic Evaluations During Early (Phase II) Drug Development Dyfrig A. HughesTom Walley Leading Article 17 September 2012 Pages: 1069 - 1077
Quality-of-Life Assessment in Patients with Benign Prostatic Hyperplasia Jose-Emilio Batista-MirandaMarta De la Cruz DiezHumberto Villavicencio Review Article 17 September 2012 Pages: 1079 - 1090
Cost Effectiveness of Treatment Options in Advanced Breast Cancer in the UK Ruth E. BrownJohn HuttonAnita Burrell Original Research Article 17 September 2012 Pages: 1091 - 1102
Cost-Effectiveness Analysis and the Consistency of Decision Making Bethan GeorgeAnthony HarrisAndrew Mitchell Original Research Article 17 September 2012 Pages: 1103 - 1109
Paclitaxel Greg L. PloskerMiriam Hurst Adis Pharmacoeconomic Drug Evaluation 17 September 2012 Pages: 1111 - 1134
Piperacillin/Tazobactam Melissa YoungGreg L. Plosker Adis Pharmacoeconomic Drug Evaluation 17 September 2012 Pages: 1135 - 1175